May 7, 2020 / 1:44 AM / 22 days ago

BRIEF-Neuren Pharmaceuticals Begins First Clinical Trial For Nnz-2591

May 7 (Reuters) - Neuren Pharmaceuticals Ltd:

* COMMENCES FIRST CLINICAL TRIAL FOR NNZ-2591

* DATA FROM TRIAL WILL FORM PART OF INVESTIGATIONAL NEW DRUG APPLICATION TO US FDA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below